Vis enkel innførsel

dc.contributor.authorThronæs, Morten
dc.contributor.authorBalstad, Trude Rakel
dc.contributor.authorBrunelli, Cinzia
dc.contributor.authorLøhre, Erik Torbjørn
dc.contributor.authorKlepstad, Pål
dc.contributor.authorVagnildhaug, Ola Magne
dc.contributor.authorKaasa, Stein
dc.contributor.authorKnudsen, Anne Kari
dc.contributor.authorSolheim, Tora Skeidsvoll
dc.date.accessioned2019-12-04T08:43:32Z
dc.date.available2019-12-04T08:43:32Z
dc.date.created2019-09-13T15:03:47Z
dc.date.issued2019
dc.identifier.citationSupportive Care in Cancer. 2019, 1-10.nb_NO
dc.identifier.issn0941-4355
dc.identifier.urihttp://hdl.handle.net/11250/2631663
dc.description.abstractBackground The pain management index (PMI) was developed to combine information about the prescribed analgesics and the self-reported pain intensity in order to assess physicians’ response to patients’ pain. However, PMI has been used to explore undertreatment of cancer pain. The present study explores prevalence of negative PMI and its associations to clinical variables, including the patient-perceived wish for more attention to pain. Methods A single-center, cross-sectional, observational study of cancer patients was conducted. Data on demographics and clinical variables, as well as patient-perceived wish for more attention to pain, were registered. PMI was calculated. Negative PMI indicates that the analgesics prescribed might not be appropriate to the pain intensity reported by the patient, and associations to negative PMI were explored by logistic regression models. Results One hundred eighty-seven patients were included, 53% had a negative PMI score. Negative PMI scores were more frequent among patients with breast cancer (OR 4.2, 95% CI 1.3, 13.5), in a follow-up setting (OR 12.1, 95% CI 1.4, 101.4), and were inversely associated to low performance status (OR 0.14, 95% CI 0.03, 0.65). Twenty-two percent of patients with negative PMI scores reported that they wanted more focus on pain management, versus 13% among patients with a non-negative PMI score; the difference was not statistically significant. Conclusion A high prevalence of negative PMI was observed, but only 1/5 of patients with a negative PMI wanted more attention to pain by their physician. Our findings challenge the use of PMI as a measure of undertreatment of cancer pain.nb_NO
dc.language.isoengnb_NO
dc.publisherSpringernb_NO
dc.titlePain management index (PMI)-does it reflect cancer patients? wish for focus on pain?nb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionacceptedVersionnb_NO
dc.source.pagenumber1-10nb_NO
dc.source.journalSupportive Care in Cancernb_NO
dc.identifier.doi10.1007/s00520-019-04981-0
dc.identifier.cristin1724550
dc.description.localcodeThis is a post-peer-review, pre-copyedit version of an article published in Supportive Care in Cancer. Locked until 9 July 2020 due to copyright restrictions. The final authenticated version is available online at: https://doi.org/10.1007/s00520-019-04981-0.nb_NO
cristin.unitcode194,65,15,0
cristin.unitcode1920,12,0,0
cristin.unitcode194,65,25,0
cristin.unitcode1920,28,0,0
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.unitnameKreftklinikken
cristin.unitnameInstitutt for sirkulasjon og bildediagnostikk
cristin.unitnameKlinikk for anestesi og intensivmedisin
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel